Skip to main content
HAE logo

Haemonetics Corporation

HAENYSEHealthcareMedical Devices

$118.28Today:- (-)1Y +141.33%

As of Oct 16, 2026 close

Market cap
$5.54B
P/E (TTM)
57.57
Forward P/E
99.67
Dividend yield
-
52-week range
$48.55$123.77
Volume (live)
-
Avg. volume (3M)
671.54K

Haemonetics Corporation (HAE) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Haemonetics Corporation stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy
Based on 10 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$125.38
+6.00% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest HAE Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Michael Petusky
Barrington
BuyMaintains
$118.00 → $140.00
Anthony Petrone
Mizuho
BuyMaintains
$95.00 → $140.00
Travis Steed
BofA Securities
BuyReiterates
$120.00 → $140.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Marie Thibault
BTIG
BuyReiterates
$110.00 → $130.00
Michael Petusky
Barrington
BuyMaintains
$118.00
Joanne Wuensch
Citi
BuyDowngrades
$92.00 → $123.00
Joanne Wuensch
Citi
BuyUpgrades
$92.00 → $123.00
Andrew Cooper
Raymond James
BuyMaintains
$105.00 → $125.00
David Rescott
Baird
BuyMaintains
$96.00 → $119.00
Travis Steed
BofA Securities
BuyReiterates
$1.00 → $120.00
Michael Matson
Needham
HoldMaintains
-
Anthony Petrone
Mizuho
BuyMaintains
$90.00 → $95.00
Anthony Petrone
Mizuho
BuyMaintains
$90.00 → $95.00
Allen Gong
JP Morgan
HoldMaintains
$86.00
Allen Gong
JP Morgan
HoldMaintains
$86.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for HAE?

The analyst consensus rating for HAE is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for HAE?

The average 12-month price target for HAE is $125.38, representing an upside of 6.0% from the Oct 16, 2026 close of $118.28.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.